X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
PharmaCompass offers a list of Linezolid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Linezolid manufacturer or Linezolid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linezolid manufacturer or Linezolid supplier.
PharmaCompass also assists you with knowing the Linezolid API Price utilized in the formulation of products. Linezolid API Price is not always fixed or binding as the Linezolid Price is obtained through a variety of data sources. The Linezolid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Linezolid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linezolid, including repackagers and relabelers. The FDA regulates Linezolid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linezolid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
CLICK HERE to find a list of Linezolid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Linezolid supplier is an individual or a company that provides Linezolid active pharmaceutical ingredient (API) or Linezolid finished formulations upon request. The Linezolid suppliers may include Linezolid API manufacturers, exporters, distributors and traders.
CLICK HERE to find a list of Linezolid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Linezolid DMF (Drug Master File) is a document detailing the whole manufacturing process of Linezolid active pharmaceutical ingredient (API) in detail. Different forms of Linezolid DMFs exist exist since differing nations have different regulations, such as Linezolid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Linezolid DMF submitted to regulatory agencies in the US is known as a USDMF. Linezolid USDMF includes data on Linezolid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Linezolid USDMF is kept confidential to protect the manufacturer’s intellectual property.
CLICK HERE to find a list of Linezolid suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Linezolid Drug Master File in Japan (Linezolid JDMF) empowers Linezolid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Linezolid JDMF during the approval evaluation for pharmaceutical products. At the time of Linezolid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
CLICK HERE to find a list of Linezolid suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Linezolid Drug Master File in Korea (Linezolid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Linezolid. The MFDS reviews the Linezolid KDMF as part of the drug registration process and uses the information provided in the Linezolid KDMF to evaluate the safety and efficacy of the drug.
After submitting a Linezolid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Linezolid API can apply through the Korea Drug Master File (KDMF).
CLICK HERE to find a list of Linezolid suppliers with KDMF on PharmaCompass.
A Linezolid written confirmation (Linezolid WC) is an official document issued by a regulatory agency to a Linezolid manufacturer, verifying that the manufacturing facility of a Linezolid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Linezolid APIs or Linezolid finished pharmaceutical products to another nation, regulatory agencies frequently require a Linezolid WC (written confirmation) as part of the regulatory process.
CLICK HERE to find a list of Linezolid suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Linezolid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Linezolid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Linezolid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Linezolid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Linezolid NDC to their finished compounded human drug products, they may choose to do so.
CLICK HERE to find a list of Linezolid suppliers with NDC on PharmaCompass.
Linezolid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Linezolid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Linezolid GMP manufacturer or Linezolid GMP API supplier for your needs.
A Linezolid CoA (Certificate of Analysis) is a formal document that attests to Linezolid's compliance with Linezolid specifications and serves as a tool for batch-level quality control.
Linezolid CoA mostly includes findings from lab analyses of a specific batch. For each Linezolid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Linezolid may be tested according to a variety of international standards, such as European Pharmacopoeia (Linezolid EP), Linezolid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Linezolid USP).
Market Place
